Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

Author： Frederick B. Dong  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.15, 2004-01, pp. : 1015-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE Inhibitor and Angiotensin II Type 1 Receptor Antagonist Therapies in Elderly Patients with Diabetes Mellitus: Are They Underutilized?

By >   Winkelmayer Wolfgang C.  

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra   O’Brien Judith A   Salas Maribel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

By Annemans L.   Marbaix S.  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 133-142

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

Improving treatment of type 1 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite